Bringing the Oncology Community Together

Lung Cancer

Latest Lung Cancer Articles View more >>
PD-L1 Predictive of Response to MK-3475 in Melanoma and NSCLC
PD-L1 Predictive of Response to MK-3475 in Melanoma and NSCLC
PD-L1 levels adequately predict response and clinical outcomes for PD-1 inhibitor MK-3475 in patients with non-small cell lung cancer (NSCLC) and melanoma
Institute Develops Fresh Bench-to-Bedside Model Through Community Ties
Institute Develops Fresh Bench-to-Bedside Model Through Community Ties
In more than 40 years as a National Cancer Institute (NCI)-designated cancer center—and the first center in the network devoted purely to basic research—The Wistar Institute has built a reputation for furthering the sort of scientific research that will improve clinical cancer medicine.
MAGE-A3 Vaccine Falters in Large Phase III NSCLC Study
MAGE-A3 Vaccine Falters in Large Phase III NSCLC Study
The large phase III MAGRIT study investigating the MAGE-A3-specific vaccine GSK1572932A for patients with non-small cell lung cancer (NSCLC) will be completely halted following an interim analysis that demonstrated a lack of benefit.
Next-Generation EGFR Inhibitor Shows Promise in Resistant NSCLC
Next-Generation EGFR Inhibitor Shows Promise in Resistant NSCLC
The next-generation EGFR inhibitor CO-1686 has demonstrated promising activity in T790M-positive patients with non-small cell lung cancer.
Ceritinib Demonstrates Impressive Response Rates in ALK-Positive NSCLC
Ceritinib Demonstrates Impressive Response Rates in ALK-Positive NSCLC
Ceritinib (LDK378) demonstrated an ORR of 58% and a median PFS of 7 months as a treatment for patients with ALK-positive non-small cell lung cancer.
Publications
External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc
OncLive Resources

Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives


About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright OncLive 2006-2014
Intellisphere, LLC. All Rights Reserved.